Primary Site >> Esophagus Cancer

Gene >> SART3

Journal: Cancer Res. 1999 Aug 15;59(16):4056-63.
Title: Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.
Author: Yang, D|Nakao, M|Shichijo, S|Sasatomi, T|Takasu, H|Matsumoto, H|Mori, K|Hayashi, A|Yamana, H|Shirouzu, K|Itoh, K
PMID: 10463607
Journal: J Urol. 2000 Dec;164(6):2090-5.
Title: Expression of the SART3 tumor rejection antigen in renal cell carcinoma.
Author: Kawagoe, N|Shintaku, I|Yutani, S|Etoh, H|Matuoka, K|Noda, S|Itoh, K
PMID: 11061933
Journal: Kurume Med J. 2001;48(1):55-8.
Title: Expression of the SART3 antigens in oral cancers.
Author: Fukuda, K
PMID: 11402621
Journal: Cancer. 2002 Mar 15;94(6):1636-41.
Title: Expression of tumor rejection antigens in colorectal carcinomas.
Author: Sasatomi, Teruo|Suefuji, Yuichi|Matsunaga, Kazuko|Yamana, Hideaki|Miyagi, Yoshiaki|Araki, Yasumi|Ogata, Yutaka|Itoh, Kyogo|Shirouzu, Kazuo
PMID: 11920522
Journal: Int J Oncol. 2010 Jan;36(1):19-27.
Title: A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer.
Author: Altiok, Soner|Mezzadra, Heather|Jagannath, Sanjay|Tsottles, Nancy|Rudek, Michelle A|Abdallah, Nadia|Berman, David|Forastiere, Arlene|Gibson, Michael K
PMID: 19956829